| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/15/2010 | WO2010080409A1 Hemifumarate salt of 1- [4- [1- ( 4 -cyclohexyl-3 -trifluoromethyl-benzyloxyimino ) -ethyl] -2 -ethyl-benzyl] -a zetidine-3-carboxylic acid |
| 07/15/2010 | WO2010080406A1 Method for treating rhinitis and sinusitis by rhamnolipids |
| 07/15/2010 | WO2010080398A1 Sulfonamides as trpm8 modulators |
| 07/15/2010 | WO2010080397A1 Sulfamides as trpm8 modulators |
| 07/15/2010 | WO2010080389A1 Hcv ns3 protease inhibitors |
| 07/15/2010 | WO2010080357A1 Serotonin 5-ht2b receptor inhibitors |
| 07/15/2010 | WO2010080345A1 Lower dosage strength imiquimod formulations and short dosing regimens for treating actinic keratosis |
| 07/15/2010 | WO2010080339A1 Phenylephrine formulations with improved stability |
| 07/15/2010 | WO2010080333A1 Arylcyclopropylacetamide derivatives useful as glucokinase activators |
| 07/15/2010 | WO2010080306A1 Purine compounds |
| 07/15/2010 | WO2010080253A1 Tricyclic azaindoles |
| 07/15/2010 | WO2010080213A2 Dry diazeniumdiolation methods for producing nitric oxide releasing medical devices |
| 07/15/2010 | WO2010080183A1 Potent non-urea inhibitors of soluble epoxide hydrolase |
| 07/15/2010 | WO2010080170A1 Combination therapies for neoplastic disorders |
| 07/15/2010 | WO2010080129A2 Extended dicer substrate agents and methods for the specific inhibition of gene expression |
| 07/15/2010 | WO2010079978A2 Composition for improving inflammatory disease using abh antigens |
| 07/15/2010 | WO2010079914A2 A composition comprising the compound isolated from the extract of rubiae radix for preventing and treating inflammatory diseases |
| 07/15/2010 | WO2010079910A2 Eyesight-protecting composition containing functional components having preventive and therapeutic efficacy in diabetes or diabetes complications |
| 07/15/2010 | WO2010079833A1 Novel cancer antigen eef2 |
| 07/15/2010 | WO2010079819A1 Pharmaceutical composition for treating obesity or diabetes |
| 07/15/2010 | WO2010079811A1 Gene sensitive to diseases associated with intervertebral disc degeneration, and use thereof |
| 07/15/2010 | WO2010079668A1 Olefin compound |
| 07/15/2010 | WO2010079514A1 A process for preparation of hexadecyl cis-9-tetradecenoate and hexadecyl cis-10-tetradecenoate |
| 07/15/2010 | WO2010079513A2 Painless treatment of warts, corns & callus |
| 07/15/2010 | WO2010079504A2 Stable r(+)-lansoprazole amine salt and a process for preparing the same |
| 07/15/2010 | WO2010079489A1 Tellurium-containing compounds for affecting female's reproductive system following chemotherapy and/or radiotherapy |
| 07/15/2010 | WO2010079488A1 Tellurium-containing compounds for affecting male's fertility following chemotherapy and/or radiotherapy |
| 07/15/2010 | WO2010079433A2 Pharmaceutical composition that includes a dipeptidyl peptidase-iv inhibitor |
| 07/15/2010 | WO2010079431A2 Compounds for the prevention and treatment of cardiovascular disease |
| 07/15/2010 | WO2010079423A1 Inhibitors of phosphatidylinositol-3-kinase (pi3) and inducers of nitric oxide (no) |
| 07/15/2010 | WO2010079406A1 Compounds and uses thereof for treating inflammation and modulating immune responses |
| 07/15/2010 | WO2010079373A1 Improved pharmaceutical formulation |
| 07/15/2010 | WO2010079305A1 Anti-snoring composition containing a thermogelling polymer |
| 07/15/2010 | WO2010079287A1 Divisible tablet containing particles coated with s-adenosyl-methionine |
| 07/15/2010 | WO2010079255A1 Use of inverse antagonists and/or agonists of cb1 receptors for preparing drugs to increase motor neurone excitability |
| 07/15/2010 | WO2010079241A1 Use of antagonists and/or inverse agonists of cb1 receptors for the preparation of drugs that increase motor neuron excitability |
| 07/15/2010 | WO2010079239A1 Novel thiazoles derivatives and their use as positive allosteric modulators of metabotropic glutamate receptors |
| 07/15/2010 | WO2010079238A1 Heterotricyclic compounds as positive allosteric modulators of metabotropic glutamate receptors |
| 07/15/2010 | WO2010079222A1 Pharmaceutical formulation comprising one or more fumaric acid esters in an erosion matrix |
| 07/15/2010 | WO2010079221A1 Pharmaceutical composition comprising one or more fumaric acid esters |
| 07/15/2010 | WO2010079197A1 Treatment of diabetes in patients with inadequate glycemic control despite metformin therapy comprising a dpp-iv inhibitor |
| 07/15/2010 | WO2010079120A1 Benzimidazole and pyrazolopyridine derivatives for treating and/or preventing cardiovascular diseases |
| 07/15/2010 | WO2010079045A2 New salts |
| 07/15/2010 | WO2010078953A1 Triazolo and tetrazolo pyrimidine derivatives as hne inhibitors for treating copd |
| 07/15/2010 | WO2010078916A1 Immunocytokines for tumour therapy with chemotherapeutic agents |
| 07/15/2010 | WO2010078911A1 Antiviral patch |
| 07/15/2010 | WO2010078910A1 Pyridazinone derivatives |
| 07/15/2010 | WO2010078909A1 Pyridazinone derivatives |
| 07/15/2010 | WO2010078905A1 Benzothiazolone derivative |
| 07/15/2010 | WO2010078897A1 Novel polymorphic forms of 3-(1-{3-[5-(1-methyl-piperidin-4ylmethoxy)-pyrimidin-2-yl]-benzyl}-6-oxo-1,6-dihydro-pyridazin-3-yl)-benzonitrile hydrochloride salt and processes of manufacturing thereof |
| 07/15/2010 | WO2010078878A1 Duloxetine formulations |
| 07/15/2010 | WO2010078867A1 Method for improved bioactivation of medications |
| 07/15/2010 | WO2010078865A1 Nω-HYDROXY-L-ARGININE DERIVATIVES FOR THE TREATMENT OF DISEASES |
| 07/15/2010 | WO2010078830A1 Benzimidazole-4-carboxamide derivatives, their preparation methods, pharmaceutical compositions and their uses |
| 07/15/2010 | WO2010078730A1 Preparation of ginsenoside-rd propylene glycol aqueous solution and new use thereof in anti-inflammation, immunosuppression and anti organ-graft rejection |
| 07/15/2010 | WO2010078711A1 Amino methanol derivants and salts thereof and their preparation methods and medical use |
| 07/15/2010 | WO2010078660A1 Use of proanthocyanidins as an anti-apoptotic agent and anti-adhesive bacterial agent |
| 07/15/2010 | WO2010078659A1 Compositions and methods for nutritional prevention and treatment of alzheimer's-associated conditions |
| 07/15/2010 | WO2010078648A1 Treatment of soft tissue injury using hyaluronic acid and botulinum toxin |
| 07/15/2010 | WO2010059916A3 Preparation of docetaxel |
| 07/15/2010 | WO2010059602A3 Inhibitors of diacylglycerol acyltransferase |
| 07/15/2010 | WO2010059226A3 Inhibition of map4k4 through rnai |
| 07/15/2010 | WO2010058032A3 Substituted pyrimidines for the treatment of diseases such as cancer |
| 07/15/2010 | WO2010057503A3 Curcumin protein conjugates |
| 07/15/2010 | WO2010057101A3 Compounds useful as hiv blockers |
| 07/15/2010 | WO2010056914A8 Bacterial helicase inhibitor compounds and uses thereof |
| 07/15/2010 | WO2010054107A3 Kinase knockdown via electrophilically enhanced inhibitors |
| 07/15/2010 | WO2010053655A3 Therapeutic methods with withaferin a and analogs |
| 07/15/2010 | WO2010051935A3 Substituted amido phenoxybenzamides |
| 07/15/2010 | WO2010051933A3 Substituted sulphonamido phenoxybenzamides |
| 07/15/2010 | WO2010048552A3 Methods of using oligomeric compounds comprising 2'-substituted nucleosides |
| 07/15/2010 | WO2010048287A9 Radioprotective agents |
| 07/15/2010 | WO2010047999A3 Method for treating pulmonary arterial hypertension |
| 07/15/2010 | WO2010046458A3 Compositions comprising vitamins |
| 07/15/2010 | WO2010045755A8 Glycosyl-derivatives of puerarin, pharmaceutical compositon, preparation method and use thereof |
| 07/15/2010 | WO2010045509A3 Modulation of factor 11 expression |
| 07/15/2010 | WO2010045306A3 Azine derivatives and methods of use thereof |
| 07/15/2010 | WO2010044108A3 Controlled release formulations of ropinirole |
| 07/15/2010 | WO2010042759A3 Gaba conjugates and methods of use thereof |
| 07/15/2010 | WO2010042292A8 Method for selectively inhibiting the activity of acat1 in the treatment of alzheimer's disease |
| 07/15/2010 | WO2010041908A3 Novel use of panduratin derivative or boesenbergia pandurata extract |
| 07/15/2010 | WO2010039762A3 Pharmaceutical compositions comprising boronic acid compounds |
| 07/15/2010 | WO2010039647A3 Selective inhibitors of c-jun n-terminal kinases |
| 07/15/2010 | WO2010037765A3 4 -morpholino-pyrido [3, 2 -d] pyrimidines active on pi3k |
| 07/15/2010 | WO2010036904A3 Preparation of valganciclovir and its salts |
| 07/15/2010 | WO2010036005A3 Pharmaceutical composition comprising risedronic acid or a salt thereof and vitamin d |
| 07/15/2010 | WO2010033658A3 Cathepsin l proteolytically processes histone h3 during mouse embroyonic stem cell differentiation |
| 07/15/2010 | WO2010030054A3 Uses of sesquiterpene derivatives |
| 07/15/2010 | WO2010025448A3 Compounds for inhibiting cell proliferation |
| 07/15/2010 | WO2010023693A3 Controlled release compositions of ropinirole |
| 07/15/2010 | WO2010023327A4 Method for obtaining oligonucleotide aptamers and uses thereof |
| 07/15/2010 | WO2010017626A8 Compositions comprising terpene compounds for treating negative sensory phenomena |
| 07/15/2010 | WO2010015567A3 Controlled release formulations using intelligent polymers |
| 07/15/2010 | WO2010013987A4 Extraction method for increasing liquiritigenin content in glycyrrhizae radix et rhizoma or glycyrrhizae radix extract |
| 07/15/2010 | WO2010008735A3 Solid states of o-desmethylvenlaf axine salts |
| 07/15/2010 | WO2010008731A9 Methods for determining sensitivity to aminoflavones |
| 07/15/2010 | WO2010001167A3 Preparation of 3-pyrrole substituted 2-indolinone derivatives |
| 07/15/2010 | WO2009149058A8 Modified release niacin formulations |
| 07/15/2010 | WO2009146034A3 Mapk/erk kinase inhibitors and methods of use thereof |
| 07/15/2010 | WO2009145956A3 Uses of calpain inhibitors to inhibit inflammation |